Dirk van Lier
Radboud University Nijmegen(NL)Radboud University Medical Center(NL)Radboud Institute for Molecular Life Sciences(NL)
Publications by Year
Research Areas
Atrial Fibrillation Management and Outcomes, Sepsis Diagnosis and Treatment, Cardiac Arrhythmias and Treatments, Antiplatelet Therapy and Cardiovascular Diseases, Heart Failure Treatment and Management
Most-Cited Works
- → Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry(2017)165 cited
- → Experimental human endotoxemia as a model of systemic inflammation(2018)93 cited
- → CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo(2023)85 cited
- → Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry(2019)80 cited
- → Increased blood angiotensin converting enzyme 2 activity in critically ill COVID-19 patients(2021)79 cited
- → Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study(2021)73 cited